Ticker Details
BridgeBio Pharma, Inc.
IPO Date:	June 24, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$14.64B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.89 | 2.98%
Avg Daily Range (30 D):	$1.30 | 1.88%
Avg Daily Range (90 D):	$1.52 | 2.07%

Institutional Daily Volume
Avg Daily Volume:	1.5M
Avg Daily Volume (30 D):	1.62M
Avg Daily Volume (90 D):	2.03M

Trade Size
Avg Trade Size (Sh.):	82
Avg Trade Size (Sh.) (30 D):	59
Avg Trade Size (Sh.) (90 D):	64

Institutional Trades
Total Institutional Trades:	8,186
Avg Institutional Trade:	$3.33M
Avg Institutional Trade (30 D):	$4.26M
Avg Institutional Trade (90 D):	$4.9M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	5

Market Closing Trades
Avg Closing Trade:	$7.89M
Avg Closing Trade (30 D):	$18.4M
Avg Closing Trade (90 D):	$22.02M
Avg Closing Volume:	249.63K

News

Mar 30, 2026 @ 7:30 PM Acoramidis Significantly Reduces the Risk of All-C... Source: Bridgebio Pharma, Inc.

Mar 11, 2026 @ 6:00 PM BBP-418 Demonstrates Consistent Efficacy and Favor... Source: Bridgebio Pharma, Inc.

Mar 10, 2026 @ 6:49 PM BridgeBio's Rare-Disease Pipeline Sparks Growth Bu... Source: Vandana Singh

Feb 22, 2026 @ 3:00 PM Blue Owl, Genuine Parts, And Okta Are Among Top 10... Source: Nabaparna Bhattacharya

Feb 17, 2026 @ 11:22 PM BridgeBio Pharma Reports Inducement Grants under N... Source: Na

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-3.78		$-3.78
Diluted EPS	$-3.78		$-3.78
Revenue	$502.08M		$502.08M
Gross Profit	$481.11M		$481.11M
Net Income / Loss	$-732.94M		$-732.94M
Operating Income / Loss	$-523.41M		$-523.41M
Cost of Revenue	$20.96M		$20.96M
Net Cash Flow	$-111.1M		$-111.1M
PE Ratio